Loading clinical trials...
Loading clinical trials...
RESET-CKD is evaluating an intervention to support Black adults with chronic kidney disease (CKD) to reduce their sedentary (e.g., sitting) time. Half of the participants will be randomized to the int...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Illinois at Chicago
Collaborators
NCT05732727 · Chronic Kidney Disease(CKD), Uncontrolled Hypertension
NCT07043166 · Metabolic Syndrome, Diabetes, and more
NCT06940414 · Hyperkalemia, Chronic Kidney Disease(CKD)
NCT07021157 · Chronic Kidney Disease(CKD)
NCT06694558 · Chronic Kidney Disease(CKD), Type 1 Diabetes (T1D)
UI Health/University of Illinois Chicago
Chicago, Illinois
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions